Simvastatin 40mg: Clinical Trials

5 trials of Simvastatin 40mg, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting, 2 recruiting, 1 terminated. 5 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 35Active not recruiting 2, Recruiting 2, Terminated 1
Phase 21Recruiting 1

Follow Simvastatin 40mg: new trials by email Literature Review of Simvastatin 40mg trials Research Report on Simvastatin 40mg

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Simvastatin in Alcoholic Liver Fibrosis
Simvastatin 40mg - Liver Fibrosis, Alcohol Abuse
Phase 2 / Phase 3RecruitingAnna Cruceta902022-02-222024-12-04
Multi-Center Study of the Effects of Simvastatin on Hepatic Decompensation and Death in Subjects Presenting With High-Risk Compensated Cirrhosis
Placebo Oral Tablet, Simvastatin 40mg - Cirrhosis
Phase 3Active not recruitingVA Office of Research and Development1422020-10-022026-11-19
Effect of Simvastatin on the Prognosis of Primary Primary Sclerosing Cholangitis (PSC)
Simvastatin 40mg, Placebo oral tablet - Primary Sclerosing Cholangitis
Phase 3Active not recruitingAnnika Bergquist5712020-10-012025-09-05
Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)
Simvastatin 40mg - Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy
Phase 3RecruitingLund University802018-01-262024-09-25
Simvastatin in the Prevention of Recurrent Pancreatitis
Simvastatin 40mg, Placebo - Pancreatitis Relapsing
Phase 3TerminatedEnrique de-Madaria832017-09-292025-03-20

Conditions studied

Alcoholism (1)  ·  Carcinoma, Hepatocellular (1)  ·  Cholangitis, Sclerosing (1)  ·  Fibrosis (1)  ·  Graves Ophthalmopathy (1)  ·  Liver Cirrhosis (1)  ·  Pancreatitis (1)  ·  Pancreatitis, Chronic (1)  ·  Recurrence (1)

Sponsors

Anna Cruceta (1)  ·  Annika Bergquist (1)  ·  Enrique de-Madaria (1)  ·  Lund University (1)  ·  VA Office of Research and Development (1)

Countries

Spain (2)  ·  Sweden (2)  ·  United States (1)

Top investigators

Annika Bergquist, MD PhD (1)  ·  David E. Kaplan, MD MSc (1)  ·  Pere Gines, Md (1)  ·  Tereza Planck, MD, PhD (1)

Results publications

PMID 33644082, PMID 39601354, PMID 40824526, PMID 41482454

NIH funding

2018 (1), I01CX002010 (1)